Trial intelligence / Profile preview

L-Carnitine and Dexamethasone for RDS Prevention in Preterm Infants

NCT03630367Phase 4Withdrawn

Sponsor
Assiut University
Start
Oct 2018
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levocarnitine in respiratory distress syndrome (RDS), sponsored by Assiut University. Planned start Oct 2018; status: withdrawn.

02

Drugs

levocarnitine
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on NCT03630367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03630367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call